Paul Burton
Technik-/Wissenschafts-/F&E-Leiter bei AMGEN INC.
Vermögen: 101 296 $ am 30.04.2024
Profil
Dr. Paul Burton ist Chief Global Medical Affairs Officer bei Janssen Pharmaceuticals, Inc. Dr. Burton war zuvor als Vizepräsident bei Janssen Research & Development LLC beschäftigt. Er erwarb seinen Hochschulabschluss an der University of London und promovierte am Imperial College London.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MODERNA, INC.
0,00% | 07.11.2022 | 954 ( 0,00% ) | 101 296 $ | 30.04.2024 |
Aktive Positionen von Paul Burton
| Unternehmen | Position | Beginn |
|---|---|---|
| AMGEN INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2023 |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2020 |
| Royal College of Surgeons | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Paul Burton
| Unternehmen | Position | Ende |
|---|---|---|
| MODERNA, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2023 |
| JOHNSON & JOHNSON | Technik-/Wissenschafts-/F&E-Leiter | - |
Janssen Research & Development LLC
 Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Corporate Officer/Principal | - |
Ausbildung von Paul Burton
| University of London | Doctorate Degree |
| Imperial College London | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| MODERNA, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Commercial Services |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
